US 12180192
Modulators of THR-β and methods of use thereof
granted A61PA61P5/14
Quick answer
US patent 12180192 (Modulators of THR-β and methods of use thereof) held by Aligos Therapeutics, Inc. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P5/14